Organization Overview
Alternative names
trabectedin (yondelis) (2000)
Acute Disease (Phase 1)
Adenocarcinoma (Phase 1)
Adnexal Diseases (Phase 2)
Aggression (Phase 2)
Bone Neoplasms (Phase 1)
Breast Diseases (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 3)
Chondrosarcoma (Phase 2)
Chondrosarcoma, Mesenchymal (Phase 2)
Colorectal Neoplasms (Phase 2)
DNA Repair-Deficiency Disorders (Phase 2)
Dry Eye Syndromes (Phase 3)
Endocrine Gland Neoplasms (Phase 2)
Endometrial Neoplasms (Phase 2)
Eye Diseases (Phase 3)
Eye Pain (Phase 2)
Fallopian Tube Neoplasms (Phase 3)
Genital Diseases, Female (Phase 2)
Genital Neoplasms, Female (Phase 2)
Glaucoma (Phase 2)
Glaucoma, Open-Angle (Phase 2)
Hepatic Insufficiency (Phase 1)
Hypertension (Phase 2)
Immunoblastic Lymphadenopathy (Phase 2)
Keratoconjunctivitis Sicca (Phase 3)
Leiomyosarcoma (Phase 3)
Leukemia (Phase 2)
Liposarcoma (Phase 3)
Liposarcoma, Myxoid (Phase 2)
Liver Failure (Phase 1)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 2)
Mesothelioma (Phase 2)
Multiple Myeloma (Phase 3)
Myelodysplastic Syndromes (Phase 1)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 3)
Neoplasms by Histologic Type (Phase 1)
Neoplasms by Site (Phase 2)
Neoplasms, Connective and Soft Tissue (Phase 1)
Neoplasms, Plasma Cell (Phase 3)
Neuroectodermal Tumors (Phase 2)
Neuroectodermal Tumors, Primitive (Phase 2)
Neuroendocrine Tumors (Phase 1)
Ocular Hypertension (Phase 2)
Ovarian Diseases (Phase 2)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 1)
Peritoneal Neoplasms (Phase 3)
Preleukemia (Phase 1)
Primary Myelofibrosis (Phase 2)
Prostatic Neoplasms (Phase 2)
Sarcoma (Phase 3)
Sarcoma, Ewing (Phase 2)
Sarcoma, Synovial (Phase 3)
Skin Diseases (Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Urogenital Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Uterine Neoplasms (Phase 2)